No results for ‘’
Genomic Valley Biotech Ltd
₹29.10
(1.29%)
Sun, 27 Sept 2026, 01:11 am
Health Technology
Biotechnology
24.5KGenomic Valley Biotech Return on Equity (ROE) History
No Result Found
| Particulars |
|---|
| Price to earnings ratio |
| Price to book ratio |
| Price to sales ratio |
| Price to cash flow ratio |
| Enterprise value |
| Enterprise value to EBITDA ratio |
| Debt to equity ratio |
| Return on equity % |
Genomic Valley Biotech Ltd Return on Equity
The Genomic Valley Biotech Ltd Return on Equity is a key financial metric used by investors to evaluate Genomic Valley Biotech Ltd's valuation, profitability, and overall financial performance. Tracking the Genomic Valley Biotech Ltd Return on Equity helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.
Genomic Valley Biotech Ltd (NSE: , BSE: 539206) is currently trading at ₹29.10, with a market capitalization of ₹0. As a leading company in the Health technology sector and Biotechnology industry, monitoring the Genomic Valley Biotech Ltd Return on Equity is essential for fundamental analysis.
Genomic Valley Biotech Ltd Return on Equity Current Value
The current Genomic Valley Biotech Ltd Return on Equity stands at 0.
The Genomic Valley Biotech Ltd Return on Equity remains stable, indicating consistent financial performance.
Genomic Valley Biotech Ltd Return on Equity Historical Trend
The Genomic Valley Biotech Ltd Return on Equity has shown the following historical trend:
The decline in Genomic Valley Biotech Ltd Return on Equity indicates improving financial efficiency or better earnings growth.
What Genomic Valley Biotech Ltd Return on Equity Indicates for Investors
The Genomic Valley Biotech Ltd Return on Equity plays a crucial role in understanding the company's financial health and valuation.
ROE indicates how efficiently the company generates returns for shareholders.
Genomic Valley Biotech Ltd Return on Equity Analysis Summary
The Genomic Valley Biotech Ltd Return on Equity remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Genomic Valley Biotech Ltd Return on Equity should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.
Regular tracking of Genomic Valley Biotech Ltd Return on Equity helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.